US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
ドイツ
TG
Smartbroker Holding AG (SB1) 銘柄情報

Smartbroker Holding AG (SB1)

11.25

0.10

( 0.90% )

更新日時： 16:42:50

Smartbroker Holding AG (SB1) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

11.25

( 0.90% )

買値

11.25

売値

11.40

出来高

500

11.25 日の範囲 11.25

10.55 52 週間の範囲 15.45

時価総額

前日終値

11.15

始値

11.25

時刻

最終取引時間

16:42:34

財務取引量

-

VWAP

-

平均取引量 (3 か月)

3,320 €

発行済株式数

16,781,252

配当利回り

PER

-42.96

1 株当たり利益 (EPS)

-0.26

歳入

59.38M

純利益

-4.43M

Smartbroker Holding AG operates as online broker in Germany. The company offers various products of traditional brokering with neo brokering conditions. It also operates through various stock market portals, including wallstreet-online.de, boersenNews.de, FinanzNachrichten.de, and ARIVA.de. In addit... Smartbroker Holding AG operates as online broker in Germany. The company offers various products of traditional brokering with neo brokering conditions. It also operates through various stock market portals, including wallstreet-online.de, boersenNews.de, FinanzNachrichten.de, and ARIVA.de. In addition, the company hosts and operates the finance community. Smartbroker Holding AG was formerly known as wallstreet:online AG. The company was founded in 1998 and is based in Berlin, Germany. 詳細を表示

セクター

Finance

業界

Capital Markets

ウェブサイト

www.smartbroker-holding.de

本社

Berlin, Germany

設立

1998

Smartbroker Holding AG is listed in the Finance sector of the Tradegate (DE) with ticker SB1. The last closing price for Smartbroker was 11.15 €. Over the last year, Smartbroker shares have traded in a share price range of 10.55 € to 15.45 €.

Smartbroker currently has 16,781,252 shares in issue. The market capitalisation of Smartbroker is 188.79 € million. Smartbroker has a price to earnings ratio (PE ratio) of -42.96.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.05	-0.442477876106	11.3	11.5	11	4238	11.07420253	DE
4	-1.2	-9.63855421687	12.45	12.7	11	2723	11.58729293	DE
12	-0.65	-5.46218487395	11.9	13.25	11	2840	12.11806215	DE
26	-4	-26.2295081967	15.25	15.45	10.8	3873	12.81548167	DE
52	-1.65	-12.7906976744	12.9	15.45	10.55	4267	12.69980235	DE
156	1.61	16.7012448133	9.64	15.45	5.56	5372	9.72961063	DE
260	2.49	28.4246575342	8.76	15.45	5.39	6371	8.99807884	DE

SB1 - Frequently Asked Questions (FAQ)

What is the current Smartbroker Holding AG share price?

The current share price of Smartbroker Holding AG is 11.25 €

How many Smartbroker Holding AG shares are in issue?

Smartbroker Holding AG has 16,781,252 shares in issue

What is the market cap of Smartbroker Holding AG?

The market capitalisation of Smartbroker Holding AG is EUR 188.79M

What is the 1 year trading range for Smartbroker Holding AG share price?

Smartbroker Holding AG has traded in the range of 10.55 € to 15.45 € during the past year

What is the PE ratio of Smartbroker Holding AG?

The price to earnings ratio of Smartbroker Holding AG is -42.96

What is the cash to sales ratio of Smartbroker Holding AG?

The cash to sales ratio of Smartbroker Holding AG is 3.21

What is the registered address of Smartbroker Holding AG?

The registered address for Smartbroker Holding AG is Ritterstraße 11, Berlin, Berlin, 10969

What is the Smartbroker Holding AG website address?

The website address for Smartbroker Holding AG is www.smartbroker-holding.de

Which industry sector does Smartbroker Holding AG operate in?

Smartbroker Holding AG operates in the Capital Markets sector

US Market News

US Market News 2分前

KBR Launches Inaugural Innovation Studio Powered by Applied Computing in BengaluruJune 16, 2026 3:35 AM
PR Newswire (US) class="legendSpanClass"BENGALURU, India, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- KBR (NYSE: KBR) launch

tkg

I don't see any end in sight for the insatiable demand for compute and data centers, to the contrary, demand is going parabolic.

Qualcomm CEO says AI agents will replace apps — as chip giant works on 40 new AI-powered devices
PUBLISHED TUE, JUN 16 20261:08 AM EDT

knrorrel

knrorrel 5分前

GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me

silattore

silattore 5分前

WOW! Umpteenth dilution. Another umpteenth times to go. Well done.
Didn't know being a CEO and managing a company is this easy, as far as AMC is concerned. You earn money or lose money, doesn't matter. There is always dilution.

If retail shareholders oppose another dilution, t

knrorrel

knrorrel 6分前

GPUS
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177706706

knrorrel

knrorrel 6分前

GPUS Everyone should keep an eye on this one; GPUS should continue to rise over the coming days and weeks. And once a deal is announced, the stock’s real future should truly take off—driven by strong revenue and massive profits. imho ,🚀 https://investorshub.advfn.com/boards/read_msg.aspx?me

CelestialSage6

CelestialSage6 17分前

Yes, I understand. Even if you combine all of that, can it beat Dupixent? Alteogen only collaborates with the best companies. On the other hand, Halozyme has signed contracts with companies that I don't even know if they are actually working with. So, it's not Alteogen signing with junk, but Halozym

CA Market News

CA Market News 17分前

Herbal Dispatch Provides Update on Domestic Retail Operations and Proprietary Brand ExpansionJune 16, 2026 3:01 AM
NewsfileVancouver, B

tkg

The Strategic Verdict

This Forbes article is a massive structural validation for long-term Lightwave shareholders. For years, the bears argued that Lightwave was a standalone science project trying to force its way into the market.

Now, the U.S. government and GlobalFou

Hellie

Hellie 26分前

11/06 , maybe you're right!

biotechinvestor1

biotechinvestor1 28分前

Here are a few of those drugs:
Ebglyss (IL-13)Adbry (IL-13)Nemluvio (IL-31 receptor)Late-stage agents such as zumilokibart.

Henk van vleuten

Henk van vleuten 29分前

When was it publiced? Maybe this why on 12june there was a huge spike on Jan 2027 15 options??

biotechinvestor1

biotechinvestor1 31分前

You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:

God Bless America

God Bless America 32分前

Of course they did not buy because they knew the regulation. Their families did buy instead.

US Market News

US Market News 32分前

Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2026June 16, 2026 3:00 AM
PR Newswire (US) class="legendSpanClass"BEIJING, class="legendSpanClass"June 16, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company

US Market News

US Market News 32分前

DXC Expands Relationship with Norske Skog to Modernize Network and Technology OperationsJune 16, 2026 3:00 AM
PR Newswire (US) Multi-year partnership delivers a modern, secure network solution while broadening DXC's role across Norske Sko

US Market News

US Market News 32分前

Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and InfrastructureJune 16, 2026 3:00 AM
PR Newswire (US) The company's revolutionary, pate

US Market News

US Market News 32分前

Elite Tech, Accessible Price - Introducing the Logitech G3 Series Mouse and Keyboard for PC GamingJune 16, 2026 3:05 AM
Business Wire Elite Precision - Unleash pro-grade speed with the G305 X SUPERLIGHT gaming mouse and G316 X 98 gaming keyboard. Featur

biotechinvestor1

biotechinvestor1 35分前

You ate wrong again! Not all Halozyme targets are public info for obvious competitive reasons.
There are number of other drugs in the class of Dupixent that halozyme might have an exclusive non-disclosed contract for. Here are a few of those drugs:
Late-stage agents such as zumilokibar

US Market News

US Market News 47分前

Unilever Scales Digital Twins Across Global Manufacturing Network with AccentureJune 16, 2026 2:59 AM
Business WireUnilever (LON: ULVR) is partnering with Accenture (NYSE: ACN) to scale the use of AI-enabled digital twins across its global manufacturing network

CelestialSage6

CelestialSage6 50分前

You can't refute it. Yes, I understand your level well.

biotechinvestor1

biotechinvestor1 56分前

Total nonsense! I have no interest in educating you.

Nemesis18

Nemesis18 56分前

She'll probably move to somewhere without any extradition treaty once the plug is finally pulled on this 'cancer vaccine' scam.?

price_and_volume

price_and_volume 59分前

Gonna have to bump the A/S then...
He said recently that they are looking at another acquisition...and he will dilute with shares to get it. Agreed - I posted the same, "where's the finance coming from for acquisitions?"...

Supposed 400MM shares going to $GTVH (believe it when

Precious Shipping Pl (PK)

0.125% IDX-LKD TREASURY ...

6.875% Gtd Su-lk Grn Nts...

Oil & Gaz Exploration & ...

Td Canadian Money Market...

Assembly Biosciences

1.96% Nts 22/07/2031

Vanguard Lifestrategy 40...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。